Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis with 3 years of treatment: results from a long-term study.
Josef S SmolenLi XieBochao JiaPeter C TaylorGerd BurmesterYoshiya TanakaAyesha EliasAnabela CardosoRob OrtmannChad WallsMaxime DougadosPublished in: Rheumatology (Oxford, England) (2021)
Treatment with baricitinib 4 mg demonstrated efficacy for up to 3 years and was well tolerated.